BCHE and early-onset autosomal dominant Alzheimer disease: Tacrine (MW 198.3 g mol-1) is a cholinesterase inhibitor that has been used for the treatment of Alzheimer’s disease [40] and is convenient for permeability measurements due to its intrinsic fluorescence [41].